Clinical Trial Update: Blood Based Assessment of sST2, Taken During and After Surgery, for Pediatric Patients With Heart Defects to Predict Heart Failure.

View source ↗

Summary

A pediatric clinical trial is evaluating a blood biomarker (sST2) measured during and after congenital heart surgery to predict heart failure in children, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Fontan Physiology

Snippet

Sponsor: Martin Schweiger | Conditions: Congenital Heart Surgery, Congenital Heart Disease in Children | Status: RECRUITING